| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3201460 | Journal of Allergy and Clinical Immunology | 2008 | 13 Pages |
Abstract
Total direct costs and asthma-related utilizations are meaningfully less in the year after being dispensed single controller ICS compared with single controller leukotriene modifiers or most combination controllers.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Robert S. MD, PhD, Joel W. PhD, Richard MS, Wansu MS, Virginia P. PhD, Brian PhD, MBA, Michael MD, MS,